For U.S Sample Clauses

The 'For U.S' clause designates that certain terms, conditions, or provisions within a contract are specifically applicable to parties, transactions, or activities within the United States. This clause typically clarifies that particular legal requirements, regulatory standards, or operational procedures are tailored to U.S. law or jurisdiction, and may differ from those in other countries. Its core function is to ensure compliance with U.S. legal frameworks and to avoid confusion by distinguishing obligations or rights that are unique to the U.S. context.
For U.S. Applicants: 6. Are you registered with Directorate of Defense Trade Controls (DDTC)? If yes, state so and provide documentation.
For U.S. If one of our suppliers or manufacturers fails to perform adequately or fulfill our needs, we may be required to incur significant costs and devote significant efforts to find new suppliers or manufacturers. We may also face delays in the development and commercialization of SM-88 and any other drug product we may develop. Our reliance on third parties may require us to share our trade secrets, which increase the possibility that a competitor will discover them or that our trade secrets will be misappropriated or disclosed. We may enter into license agreements with third parties with respect to SM-88 any other drug products we may develop that may place the development of SM-88 and any other drug products partially or entirely outside of our control, may require us to relinquish important rights or may otherwise be on terms unfavorable to us and, if our collaborations are not successful, SM-88 and any other drug products we may choose to develop may not reach their full market potential. Our future operational success depends on our ability to retain our key executives and to attract, retain and motivate qualified personnel. We expect to expand our development, regulatory and marketing capabilities and, as a result, we may encounter difficulties in managing our growth, which could disrupt our operations. Business disruptions (domestic and/or international) could seriously harm our future revenue and financial condition and increase our costs and expenses. Our internal computer systems or those of our CROs or other contractors or consultants, may fail or suffer security breaches, which could result in a material disruption of our drug development program. Substantial amounts of information concerning our products, employees, consultants, vendors, service providers and ongoing business are stored digitally and are subject to threats of theft, tampering, or other intrusion. Our business and operations would suffer in the event of system failures. We rely significantly on information technology and any failure, inadequacy, interruption or security lapse of that technology, including any cybersecurity incidents, could harm our ability to operate our business effectively. Our ability to successfully commercialize our technology and drug candidate may be materially adversely affected if we are unable to obtain and maintain effective IP. We may not be able to protect our IP rights throughout the world. Obtaining and maintaining our patent protection depends upon c...
For U.S. City, County, and State Government Entities. If Customer is a U.S. city, county or state government entity, then the Agreement will be silent regarding governing law and venue.
For U.S. Persons. Subscriber is a natural person who is (i) a citizen of the United States or (ii) a resident of the United States, even if not a citizen. ​
For U.S federal income tax purposes, except as otherwise provided in this Section 6.3, each item of income, gain, loss and deduction shall be allocated among the Members in the same manner as its corresponding item of book income, gain, loss or deduction is allocated pursuant to Section 6.1 and Section 6.2.
For U.S. Participants only] Either party may terminate the employment relationship for any reason at any time upon giving the other party thirty (30) days prior written notice. The Company may, in its discretion, relieve the Participant of some or all of his/her duties during all or a part of such notice period. Subject to the forgoing notice obligation, the Participant’s employment with the Company shall remain at will.
For U.S. Employees (i.e., those that are eligible and authorized to work in the United States without needing to obtain a special work visa, regardless of living in the United States or elsewhere), the Recruitment Location will be from the location in which the employee was first hired (e.g., home, unemployment office, Bard office, or other specified recruitment location at the time of hire). For U.S. employees that continue to work the season with the Company in its various geographic locations, the costs shall be reimbursed from the last work location to the next work location. Employees with a Recruitment Location in Bard or other location within normal commuting distance from Yuma, Arizona, shall be ineligible for any reimbursements for travel or subsistence.
For U.S. Government End Users: The Licensed Software is a “commercial item,” as that term is defined at 48 C.F.R. 2.101 (OCT 1995), and more specifically is “commercial computer software” and “commercial computer software documentation,” as such terms are used in 48 C.F.R. 12.212 (SEPT 1995). Consistent with 48 C.F.R. 12.212 and 48 C.F.R. 227.7202-1 through 227.7202-4 (JUNE 1995), the Licensed Software is provided to U.S. Government End Users(a) only as a commercial end item and (b) with only those rights as are granted to all other End Users pursuant to the terms and conditions herein.
For U.S. (i) a company secretary or director of us or an employee of ours whose title includes the word manager or director; (ii) a person who is acting temporarily in one of those positions; or (iii) a person or a person holding a position nominated by us to you or the guarantor; and
For U.S. (i.e., domestic) due diligence investigations, conduct the following reviews, subject to Sections III.1, III.2 and III.3, above, as applicable: For International due diligence investigations, conduct the following reviews, subject to Sections III.1, III.2 and III.3, above, as applicable: